
Pharma Pulse 12/4/24: Predicting and Influencing Patient Behavior, FDA Blocks Flavored E-Cigs & more
The latest news for pharma industry insiders.
In this part of his Pharmaceutical Executive video interview, Bill Grambley, CEO of AllazoHealth, explains how AI can be leveraged to create highly personalized patient engagement strategies, tailored to individual needs and preferences.
E-cigarette manufacturers claim the products aid in smoking cessation for adults without the risk of adolescent usage.
The company’s megacluster of chips for artificial-intelligence startup Anthropic will be among the world’s largest, it said, and its new giant server will lower the cost of AI as it seeks to build an alternative to Nvidia.
Phenom released its State of High-Volume Hiring: 2025 Benchmarks Report, which analyzed 101 companies on their maturity and use of artificial intelligence (AI) and automation technology to hire frontline, hourly, seasonal and high-turnover roles across Retail, Hospitality & Travel, Healthcare & Pharmaceuticals, Manufacturing, and Transportation & Distribution. While many have started adopting and implementing AI and automation to attract and hire best-fit candidates efficiently, the audit revealed only 32% demonstrated widespread adoption — indicating challenges in managing fluctuating workforce demands amid competitive labor markets.
Very excited to share that I'll be moderating a panel at Trade & Channel Strategies in Philadelphia that revolves around "Wall Street and Investment Insights — Analyze Market Dynamics and Key Investments in Life Sciences." You won't want to miss the insight that Joyce Lau and Shawn Pelc have to offer on the morning of Dec. 10.
I'll also be there for the remainder of the show covering some of the other sessions and conducting on-site video interviews on behalf of
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

